Membranous nephropathy following intravitreal injection of bevacizumab
Publication
, Journal Article
Anto, HR; Hyman, GF; Li, JP; Spitalewitz, S; Thomas, D
Published in: Canadian Journal of Ophthalmology
February 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Canadian Journal of Ophthalmology
DOI
ISSN
0008-4182
Publication Date
February 2012
Volume
47
Issue
1
Start / End Page
84 / 86
Publisher
Elsevier BV
Related Subject Headings
- Ophthalmology & Optometry
- 1113 Opthalmology and Optometry
Citation
APA
Chicago
ICMJE
MLA
NLM
Anto, H. R., Hyman, G. F., Li, J. P., Spitalewitz, S., & Thomas, D. (2012). Membranous nephropathy following intravitreal injection of bevacizumab. Canadian Journal of Ophthalmology, 47(1), 84–86. https://doi.org/10.1016/j.jcjo.2011.12.024
Anto, Heino R., George F. Hyman, Jin Ping Li, Samuel Spitalewitz, and David Thomas. “Membranous nephropathy following intravitreal injection of bevacizumab.” Canadian Journal of Ophthalmology 47, no. 1 (February 2012): 84–86. https://doi.org/10.1016/j.jcjo.2011.12.024.
Anto HR, Hyman GF, Li JP, Spitalewitz S, Thomas D. Membranous nephropathy following intravitreal injection of bevacizumab. Canadian Journal of Ophthalmology. 2012 Feb;47(1):84–6.
Anto, Heino R., et al. “Membranous nephropathy following intravitreal injection of bevacizumab.” Canadian Journal of Ophthalmology, vol. 47, no. 1, Elsevier BV, Feb. 2012, pp. 84–86. Crossref, doi:10.1016/j.jcjo.2011.12.024.
Anto HR, Hyman GF, Li JP, Spitalewitz S, Thomas D. Membranous nephropathy following intravitreal injection of bevacizumab. Canadian Journal of Ophthalmology. Elsevier BV; 2012 Feb;47(1):84–86.
Published In
Canadian Journal of Ophthalmology
DOI
ISSN
0008-4182
Publication Date
February 2012
Volume
47
Issue
1
Start / End Page
84 / 86
Publisher
Elsevier BV
Related Subject Headings
- Ophthalmology & Optometry
- 1113 Opthalmology and Optometry